Rise and shine, everyone, another busy day is on the way. We are particularly busy here at the Pharmalot campus this morning as we have successfully hustled the short person out the door to the local schoolhouse and satisfied the perpetual cravings of the official mascots. In fact, we barely have the time to fire up the coffee kettle. But we will tend to that momentarily. Meanwhile, here are some tidbits to get you going. As always, we hope you have a simply smashing day and conquer the world. …

The U.S. Department of Justice move to file a “statement of interest” in the massive litigation against opioid makers and distributors is saber rattling, as far as some lawyers and consumer advocates are concerned, NBC News says. If the DOJ were serious about holding drug makers accountable, the government would join the hundreds of cities, states, and other local governments that have accused the companies of creating a crisis. “The statement of interest does not make the government a party to the lawsuit,” trial lawyer Jesse Gessin tells the network.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy